Results (Tables)

6 Months Ended

Jun. 30, 2020

Results

Summary of R&D expenditure by program

	Six months ended June 30,
	2020		2019
	(Euro, in thousands)
Filgotinib program	€	(65,541)	€	(30,406)
Ziritaxestat program		(29,790)		(41,668)
OA program on GLPG1972		(12,499)		(9,733)
Toledo program		(37,557)		(11,869)
AtD program on MOR106		(9,518)		(12,460)
CF program		(176)		(1,793)
Other programs		(110,797)		(69,638)
Total R&D expenditure	€	(265,877)	€	(177,567)